Lany Kimmons (@lanykimmons) 's Twitter Profile
Lany Kimmons

@lanykimmons

Strategic Communications @MDAndersonNews. All opinions are my own.

ID: 956578397702049792

calendar_today25-01-2018 17:23:57

94 Tweet

354 Takipçi

477 Takip Edilen

MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

We’re proud to see Dr. Christopher Flowers on Becker's Hospital Review's 75 Black healthcare leaders to know list. A physician-scientist, leader and mentor, he's committed to promoting the careers of minority and women clinical investigators. fal.cn/3nq8M Christopher Flowers #EndCancer

We’re proud to see Dr. Christopher Flowers on <a href="/BeckersHR/">Becker's Hospital Review</a>'s 75 Black healthcare leaders to know list. A physician-scientist, leader and mentor, he's committed to promoting the careers of minority and women clinical investigators. fal.cn/3nq8M <a href="/ChrisRFlowersMD/">Christopher Flowers</a> #EndCancer
MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

#ASCO22 LBA502: The Phase III SHINE clinical trial led by Dr. Michael Wang found that ibrutinib plus bendamustine-rituximab improved progression-free survival in mantle cell lymphoma patients over age 65: bit.ly/3GKmVJH @MichaelWangMD #EndCancer

#ASCO22 LBA502: The Phase III SHINE clinical trial led by Dr. Michael Wang found that ibrutinib plus bendamustine-rituximab improved progression-free survival in mantle cell lymphoma patients over age 65: bit.ly/3GKmVJH @MichaelWangMD #EndCancer
MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

"Is the anxiety of toxicity to radiation going to cause more anxiety or worry than the breast cancer coming back? That might influence what choice you make," says our Dr. Wendy Woodward. Wendy Woodward MDPhD #EndCancer

MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

Our experts are headed to Chicago for #ASCO23, where they will be presenting 129 abstracts. Stop by MD Anderson’s booth, 14030, to discuss our research and clinical breakthroughs. And, keep up with us at ASCO here: MDAnderson.org/ASCO ASCO #EndCancer

Lany Kimmons (@lanykimmons) 's Twitter Profile Photo

Breast cancer isn't one disease. Amazing women who advocated to get individualized breast cancer treatment for specific subtypes MD Anderson Cancer Center. #EndCancer Jason A. Mouabbi MD #BreastCancerAwareness

MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

Stage IV endometrial cancer survivor Julie Dillard got a second chance at life thanks to a clinical trial led by our Dr. Shannon Westin. Watch her story and learn more about the clinical trial: bit.ly/3S8PlVr Shannon Westin, MD, MPH, FASCO #GynCSM #ESMO23 #EndCancer

MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

Combining ribociclib with hormone therapy improves disease-free survival for patients with early-stage breast cancer, according to findings presented by our Dr. Gabriel Hortobagyi at #SABCS23. brnw.ch/21wF9m3 #EndCancer

Combining ribociclib with hormone therapy improves disease-free survival for patients with early-stage breast cancer, according to findings presented by our Dr. Gabriel Hortobagyi at #SABCS23. brnw.ch/21wF9m3 #EndCancer
MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

Why is diagnosing colorectal cancer in young adults so challenging? Our Dr. Scott Kopetz shares his insights. bit.ly/3GLTckm NBC News Scott Kopetz #ColorectalCancer #EndCancer

Lany Kimmons (@lanykimmons) 's Twitter Profile Photo

New research from MD Anderson Cancer Center shows that you can safely change the breast cancer treatment sequence. This means less delays for treatment and better quality of life for patients. #EndCancer #breastcancer

MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

Born in the 1990s or later? Your risk of developing colorectal cancer is higher than if you were born in the 1950s. Read more here: brnw.ch/21wRo6N #EndCancer